glp 1 discovery of GLP-1–Based Drugs for the Treatment of Obesity Metabolic Messengers: glucagon-like peptide 1
Description
SELECT Trial (NEJM 2023)
However, individuals who have type 2 diabetes alongside a need to minimise weight gain or promote weight loss may benefit from GLP-1/GIP therapy and its dual impact on type 2 diabetes management and weight loss
By integrating advanced medication tracking with personalized lifestyle guidance, his patient-centered approach ensures you can successfully curb intense cravings, improve blood glucose control, and reach your target weight safely
Where can I view the current altRx GLP-1 offer
Osmotic laxatives
3 readout for Lillys lead oral GLP-1R agonist, orforglipron
